Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review

Rachel Neuendorf, Aubrey Harding, Noelle Stello, Douglas Hanes, Helana Wahbeh

Research output: Contribution to journalReview article

72 Citations (Scopus)

Abstract

Objective An increasing number of studies have been conducted to look at anxiety and depression in IBD; however, there is no clear consensus on the prevalence of anxiety and depression in this population. The objective of this systematic review was to compile the existing data on the prevalence of all mood and anxiety disorders in Inflammatory Bowel Disease patients. Methods A series of comprehensive literature searches of Medline, Cochrane Library, PsycINFO, CINAHL, Embase, AMED, and ProQuest Dissertations were performed through March 2014. Inclusion criteria included peer-reviewed, published scientific articles that reported a measurement of mood or anxiety among IBD patients. Only studies with adults (≥ 18 years old) and with more than 10 patients were included. Methodological quality was assessed for all included studies. Results 171 articles were identified with a total of 158,371 participants. Pooled prevalence estimate for anxiety disorders was 20.5% [4.9%, 36.5%] and 35.1% [30.5, 39.7%] for symptoms of anxiety. IBD patients in active disease had higher prevalence of anxiety of 75.6% [65.5%, 85.7%] compared to disease remission. Pooled prevalence of depression disorders was 15.2% [9.9%, 20.5%] and was 21.6% [18.7%, 24.3%] for symptoms of depression. The prevalence of depressive symptoms was higher in Crohn's disease (25.3% [20.7%, 30.0%]) compared to UC, and higher with active disease (40.7% [31.1%, 50.3%]) compared to IBD patients in remission. Conclusion Results from this systematic review indicate that patients with IBD have about a 20% prevalence rate of anxiety and a 15% prevalence rate of depression.

Original languageEnglish (US)
Pages (from-to)70-80
Number of pages11
JournalJournal of Psychosomatic Research
Volume87
DOIs
StatePublished - Aug 1 2016

Fingerprint

Inflammatory Bowel Diseases
Anxiety
Depression
Anxiety Disorders
Mood Disorders
Crohn Disease
Libraries
Consensus
Population

Keywords

  • Anxiety
  • Crohn's disease
  • Depression
  • Inflammatory Bowel Disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Depression and anxiety in patients with Inflammatory Bowel Disease : A systematic review. / Neuendorf, Rachel; Harding, Aubrey; Stello, Noelle; Hanes, Douglas; Wahbeh, Helana.

In: Journal of Psychosomatic Research, Vol. 87, 01.08.2016, p. 70-80.

Research output: Contribution to journalReview article

Neuendorf, Rachel ; Harding, Aubrey ; Stello, Noelle ; Hanes, Douglas ; Wahbeh, Helana. / Depression and anxiety in patients with Inflammatory Bowel Disease : A systematic review. In: Journal of Psychosomatic Research. 2016 ; Vol. 87. pp. 70-80.
@article{bf0dfe282adc4fd69af824ed8e619f1d,
title = "Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review",
abstract = "Objective An increasing number of studies have been conducted to look at anxiety and depression in IBD; however, there is no clear consensus on the prevalence of anxiety and depression in this population. The objective of this systematic review was to compile the existing data on the prevalence of all mood and anxiety disorders in Inflammatory Bowel Disease patients. Methods A series of comprehensive literature searches of Medline, Cochrane Library, PsycINFO, CINAHL, Embase, AMED, and ProQuest Dissertations were performed through March 2014. Inclusion criteria included peer-reviewed, published scientific articles that reported a measurement of mood or anxiety among IBD patients. Only studies with adults (≥ 18 years old) and with more than 10 patients were included. Methodological quality was assessed for all included studies. Results 171 articles were identified with a total of 158,371 participants. Pooled prevalence estimate for anxiety disorders was 20.5{\%} [4.9{\%}, 36.5{\%}] and 35.1{\%} [30.5, 39.7{\%}] for symptoms of anxiety. IBD patients in active disease had higher prevalence of anxiety of 75.6{\%} [65.5{\%}, 85.7{\%}] compared to disease remission. Pooled prevalence of depression disorders was 15.2{\%} [9.9{\%}, 20.5{\%}] and was 21.6{\%} [18.7{\%}, 24.3{\%}] for symptoms of depression. The prevalence of depressive symptoms was higher in Crohn's disease (25.3{\%} [20.7{\%}, 30.0{\%}]) compared to UC, and higher with active disease (40.7{\%} [31.1{\%}, 50.3{\%}]) compared to IBD patients in remission. Conclusion Results from this systematic review indicate that patients with IBD have about a 20{\%} prevalence rate of anxiety and a 15{\%} prevalence rate of depression.",
keywords = "Anxiety, Crohn's disease, Depression, Inflammatory Bowel Disease, Ulcerative colitis",
author = "Rachel Neuendorf and Aubrey Harding and Noelle Stello and Douglas Hanes and Helana Wahbeh",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.jpsychores.2016.06.001",
language = "English (US)",
volume = "87",
pages = "70--80",
journal = "Journal of Psychosomatic Research",
issn = "0022-3999",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Depression and anxiety in patients with Inflammatory Bowel Disease

T2 - A systematic review

AU - Neuendorf, Rachel

AU - Harding, Aubrey

AU - Stello, Noelle

AU - Hanes, Douglas

AU - Wahbeh, Helana

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objective An increasing number of studies have been conducted to look at anxiety and depression in IBD; however, there is no clear consensus on the prevalence of anxiety and depression in this population. The objective of this systematic review was to compile the existing data on the prevalence of all mood and anxiety disorders in Inflammatory Bowel Disease patients. Methods A series of comprehensive literature searches of Medline, Cochrane Library, PsycINFO, CINAHL, Embase, AMED, and ProQuest Dissertations were performed through March 2014. Inclusion criteria included peer-reviewed, published scientific articles that reported a measurement of mood or anxiety among IBD patients. Only studies with adults (≥ 18 years old) and with more than 10 patients were included. Methodological quality was assessed for all included studies. Results 171 articles were identified with a total of 158,371 participants. Pooled prevalence estimate for anxiety disorders was 20.5% [4.9%, 36.5%] and 35.1% [30.5, 39.7%] for symptoms of anxiety. IBD patients in active disease had higher prevalence of anxiety of 75.6% [65.5%, 85.7%] compared to disease remission. Pooled prevalence of depression disorders was 15.2% [9.9%, 20.5%] and was 21.6% [18.7%, 24.3%] for symptoms of depression. The prevalence of depressive symptoms was higher in Crohn's disease (25.3% [20.7%, 30.0%]) compared to UC, and higher with active disease (40.7% [31.1%, 50.3%]) compared to IBD patients in remission. Conclusion Results from this systematic review indicate that patients with IBD have about a 20% prevalence rate of anxiety and a 15% prevalence rate of depression.

AB - Objective An increasing number of studies have been conducted to look at anxiety and depression in IBD; however, there is no clear consensus on the prevalence of anxiety and depression in this population. The objective of this systematic review was to compile the existing data on the prevalence of all mood and anxiety disorders in Inflammatory Bowel Disease patients. Methods A series of comprehensive literature searches of Medline, Cochrane Library, PsycINFO, CINAHL, Embase, AMED, and ProQuest Dissertations were performed through March 2014. Inclusion criteria included peer-reviewed, published scientific articles that reported a measurement of mood or anxiety among IBD patients. Only studies with adults (≥ 18 years old) and with more than 10 patients were included. Methodological quality was assessed for all included studies. Results 171 articles were identified with a total of 158,371 participants. Pooled prevalence estimate for anxiety disorders was 20.5% [4.9%, 36.5%] and 35.1% [30.5, 39.7%] for symptoms of anxiety. IBD patients in active disease had higher prevalence of anxiety of 75.6% [65.5%, 85.7%] compared to disease remission. Pooled prevalence of depression disorders was 15.2% [9.9%, 20.5%] and was 21.6% [18.7%, 24.3%] for symptoms of depression. The prevalence of depressive symptoms was higher in Crohn's disease (25.3% [20.7%, 30.0%]) compared to UC, and higher with active disease (40.7% [31.1%, 50.3%]) compared to IBD patients in remission. Conclusion Results from this systematic review indicate that patients with IBD have about a 20% prevalence rate of anxiety and a 15% prevalence rate of depression.

KW - Anxiety

KW - Crohn's disease

KW - Depression

KW - Inflammatory Bowel Disease

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84976384950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976384950&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychores.2016.06.001

DO - 10.1016/j.jpsychores.2016.06.001

M3 - Review article

C2 - 27411754

AN - SCOPUS:84976384950

VL - 87

SP - 70

EP - 80

JO - Journal of Psychosomatic Research

JF - Journal of Psychosomatic Research

SN - 0022-3999

ER -